Navigation Links
MGuard(TM) Coronary Stent System Approved in Israel
Date:12/8/2008

n MD and Dariusz Dudek MD.

In the past year, MGuard(TM) has been successfully implanted in complex lesions in live cases at major interventional cardiology congresses such as JIM '08, PCR '08 and TCT '08. The procedures were performed by top opinion leaders including Prof. Antonio Colombo, Prof. Eberhard Grube and Dr. Dariusz Dudek. Two clinical trials with MGuard(TM) are currently underway. The MAGICAL Trial (MGuard in SVG and Native Coronaries Trial) is being conducted in Brazil and the GUARD Trial (MGuard in Acute Myocardial Infarction Study) in Poland. The main objective of the MAGICAL trial is to investigate the safety and efficacy of the MGuard stent in human subjects who are candidates for a PCI due to a narrowing of a native coronary artery or a bypass graft. Since November 2007, 24 patients out of 60 planned have been enrolled. Preliminary angiographic data has demonstrated high acute gain and minimal residual stenosis within the stented segment. Six-month angiographic follow-up has started and enrollment is ongoing.

The GUARD Study is a prospective, multi center study, designed to confirm the feasibility, efficacy and safety of MGuard(TM) in acute MI patients. The GUARD study has reached 18 patients (out of the 60 planned) with acute STEMI who received the MGuard stent with no additional distal embolization or aspiration device. The primary endpoint is ST resolution and TIMI flow, and follow up is up to six months. The study's primary endpoints are complete resolution of ST-segment elevation and restoration of flow through the occluded artery. Intermediate results will be presented this week at the ICI '08 Meeting in Tel-Aviv. iMOS (international MGuard Observational study) will be launched soon. The iMOS study will enroll 1000 patients in an open registry.

About InspireMD

InspireMD, Ltd. is an innovative medical device company focusing on the development and commercialization
'/>"/>

SOURCE InspireMD, Ltd.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Cypher(R) Sirolimus-Eluting Coronary Stent Demonstrates Sustained Clinical Benefits Compared to Bare Metal Stents in Five-Year Randomized Clinical Trial With No Differences in Long-Term Safety
2. Two-Year Outcomes From Large Head-to-Head Clinical Trial Indicate Similar Safety Profile in Diabetic Patients for Cypher(R) Sirolimus-Eluting Coronary Stent and Taxus Stent
3. Largest Study to Date Shows Significant Reductions in Risks of Blood Clots and Reintervention With CYPHER(R) Sirolimus-eluting Coronary Stent Compared to Taxus Stent
4. Four Analyses of Three-Year Clinical Data Suggest CYPHER(R) Sirolimus-Eluting Coronary Stent May Provide Alternative to Surgery for Patients with Multivessel Disease
5. Surgery More Likely Than Angioplasty to Relieve Pain for Patients With Coronary Artery Disease
6. Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007
7. Plavix(R) Indications Expanded in Japan to Include Patients with Acute Coronary Syndrome for Whom Percutaneous Coronary Intervention Is Being Planned
8. Abbotts XIENCE(TM) V Everolimus Eluting Coronary Stent Shows Continued Superiority to TAXUS Stent in Reducing Major Adverse Cardiac Events in SPIRIT III Clinical Trial
9. Abbott Announces Positive One-Year Results from the Worlds First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent
10. CorNova Preclinical Results of Valecor Platinum(TM) Coronary Stent Studies Presented at TCT 2007 Conference
11. VIA Pharmaceuticals Expands Clinical Trial Program for VIA-2291 in Acute Coronary Syndrome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... -- Accuray Incorporated (Nasdaq: ARAY ), a global ... its president and chief executive officer, Euan S. Thomson, ... J.P. Morgan Healthcare Conference in San Francisco on Wednesday, ... ,, A live webcast of each presentation will ... the Company,s Web site at http://www.accuray.com . ...
(Date:12/16/2009)... DATATRAK International, Inc. (OTCQX: DATA), ... global eClinical solutions for the clinical trials ... version 9.0 eClinical Software. This release ... and service delivery and introduces two new ... the DATATRAK Learning Center(TM) and the DATATRAK ...
(Date:12/16/2009)... -- HealthWarehouse.com, Inc. (OTC Bulletin Board: HEWA) an online ... million in 12% per annum short term debt financing. ... initial drawdown of $500,000, with accrued interest and principal ... with accrued interest and principal repayable in one year ... cashflow positive for any calendar month prior to December ...
Breaking Medicine Technology:Accuray Incorporated to Present at 28th Annual J. P. Morgan Healthcare Conference 2DATATRAK's eClinical(TM) 9.0 Software Release furthers Vision of DATATRAK ONE(TM) 2DATATRAK's eClinical(TM) 9.0 Software Release furthers Vision of DATATRAK ONE(TM) 3DATATRAK's eClinical(TM) 9.0 Software Release furthers Vision of DATATRAK ONE(TM) 4HealthWarehouse.com, Inc. Secures $1 Million in Debt Financing 2National Alliance for Hispanic Health Applauds Confirmation of Sonia Sotomayor as the Nations 111th Supreme Court Justice 53920 1Hill Rom Reports Third Quarter Financial Results 53916 1Hill Rom Reports Third Quarter Financial Results 53916 2Hill Rom Reports Third Quarter Financial Results 53916 3Hill Rom Reports Third Quarter Financial Results 53916 4Hill Rom Reports Third Quarter Financial Results 53916 5Hill Rom Reports Third Quarter Financial Results 53916 6Hill Rom Reports Third Quarter Financial Results 53916 7Hill Rom Reports Third Quarter Financial Results 53916 8Hill Rom Reports Third Quarter Financial Results 53916 9Hill Rom Reports Third Quarter Financial Results 53916 10Hill Rom Reports Third Quarter Financial Results 53916 11Hill Rom Reports Third Quarter Financial Results 53916 12Hill Rom Reports Third Quarter Financial Results 53916 13Hill Rom Reports Third Quarter Financial Results 53916 14Hill Rom Reports Third Quarter Financial Results 53916 15Hill Rom Reports Third Quarter Financial Results 53916 16Hill Rom Reports Third Quarter Financial Results 53916 17Hill Rom Reports Third Quarter Financial Results 53916 18AutoImmune Inc Reports 2009 Second Quarter Financial Results 13438 1AutoImmune Inc Reports 2009 Second Quarter Financial Results 13438 2AutoImmune Inc Reports 2009 Second Quarter Financial Results 13438 3AutoImmune Inc Reports 2009 Second Quarter Financial Results 13438 4AutoImmune Inc Reports 2009 Second Quarter Financial Results 13438 5
(Date:12/17/2009)... Motionsoft, Inc. announced today that it ... (PCI) Data Security Standards (DSS) certification, making it ... in the health and wellness space that has ... is the result of a collaborative effort formed ... International, MasterCard Worldwide, American Express, Discover Financial Services ...
(Date:12/17/2009)... PHILADELPHIA, Dec. 17 The recently opened ... already out in the community in full force this ... Run on December 13th, benefiting the Arthritis Foundation, a ... of arthritis. The event boasted 1,500 attendees, spotlighting LSI,s ... Run is a renowned, national fundraiser and a festive ...
(Date:12/17/2009)... and glutathione S-transferase T1 (GSTT1) null genotypes have been ... regarding the association between GSTM1 and GSTT1 null genotypes ... However, the majority of previous reports are limited by ... GSTM1/GSTT1 null genotype with the risk of GC and ... numbers of samples. , A research article to ...
(Date:12/17/2009)... DIEGO (December 17, 2009) Researchers from the ... aim at several of the world,s most dangerous infectious ... a five-year, $18.8 million federally-funded set of projects seeking ... , The Institute received four project awards ... and Infectious Diseases (NIAID), part of the National Institutes ...
(Date:12/17/2009)... one day provide therapeutic options for muscle and bone ... the umbilical cord, just as the blood that goes ... disorders, said University of Pittsburgh School of Medicine researchers ... Journal of Biomedicine and Biotechnology . , Umbilical ... are remarkably stable and might not trigger strong immune ...
Breaking Medicine News(10 mins):Health News:Motionsoft Completes PCI Compliance Certification 2Health News:Laser Spine Institute (LSI) Supports Jingle Bell Run 2Health News:NIH awards La Jolla Institute $18.8 million for major infectious disease study 2Health News:NIH awards La Jolla Institute $18.8 million for major infectious disease study 3Health News:NIH awards La Jolla Institute $18.8 million for major infectious disease study 4Health News:NIH awards La Jolla Institute $18.8 million for major infectious disease study 5Health News:Umbilical cord could be new source of plentiful stem cells, say Pitt researchers 2
... to the memory and scientific accomplishments of Dr. Judah ... and shed light on the link between blood supply ... (Volume 6, Number 3-4) of Lymphatic Research and ... the research impact of one of the pre-eminent physician-scientists ...
... a child born with cleft lip and palate often have ... a normal life. For some, this year,s resolution will ... philanthropy, members of the American Society of Plastic Surgeons (ASPS) ... give than to receive," by traveling overseas on behalf of ...
... Calif., Jan. 7 The surgical lights are on, ... West Coast,s most,advanced pediatric surgery center, at Lucile Packard ... (Photo: http://www.newscom.com/cgi-bin/prnh/20090107/AQW023 ) , ... in December, provide the,latest in imaging and communication technologies, ...
... ZMH ; SWX: ZMH) announced today it will be ... on January 13, 2009,at 12:00 p.m. Eastern Time. , ... via Zimmer,s Investor,Relations website at http://investor.zimmer.com . The webcast ... About the Company , Founded in ...
... admission PHILADELPHIA, Jan. 7 /PRNewswire/ -- ... year,s Healthy Kids Fest on Sunday, January 11, 2009, at ... to 5 p.m. Just in time for those New Year,s ... and free activities for the whole family.The Blue Cross RiverRink ...
... L.P. today announced that it has settled a lawsuit brought ... in October 2005 pertaining to Medicaid reimbursements paid by the ... a full release of claims, Dey has agreed to pay ... 2007 acquisition agreement between Mylan Inc. (Dey,s parent company) and ...
Other Medicine News:Health News:Festschrift Issue honoring Judah Folkman, M.D., in Lymphatic Research and Biology 2Health News:New year brings new hope to children born with cleft lip, palate 2Health News:Packard Children's Opens West Coast's Most Advanced Pediatric Surgery Center 2Health News:Packard Children's Opens West Coast's Most Advanced Pediatric Surgery Center 3Health News:Packard Children's Opens West Coast's Most Advanced Pediatric Surgery Center 4Health News:Families Encouraged to Enjoy Healthy Kids Fest at the Blue Cross RiverRink January 11 2Health News:Dey L.P. Settles State of Mississippi Pricing Litigation 2
... MJS anatomic knee system ... durability, minimize polyethylene wear ... to minimize contact stress ... to achieve a well ...
The Balanced Knee™ system provides instrumentation designed to achieve proper tissue balancing and alignment with user-friendly instrumentation that provides reproducible results....
... a cruciate sparing version which provides ... both resurfacing and inset patellas. Precision ... and fit with tibial articular surface ... cutting guide peg locations provide easy ...
... a femoral option and tibial insert which provides ... 60 degrees of flexion to induce a smooth ... degrees of flexion. Femoral component comes in a ... The constrained tibial insert in conjunction with the ...
Medicine Products: